Andy Hee-Meng Tan (Kong-Peng Lam)

Years Active: 2020-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Chelsia Qiuxia Wang, Fong Chan Choy, Arleen Sanny, Takashi Murakami, Andy Hee-Meng Tan, Kong-Peng Lam
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells 12 (2) (2023)
Chelsia Qiuxia Wang, Fong Chan Choy, Arleen Sanny, Takashi Murakami, Andy Hee-Meng Tan, Kong-Peng Lam
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells 12 (2) (2023)
Chelsia Qiuxia Wang, Fong Chan Choy, Arleen Sanny, Takashi Murakami, Andy Hee-Meng Tan, Kong-Peng Lam
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells 12 (2) (2023)
Chelsia Qiuxia Wang, Fong Chan Choy, Arleen Sanny, Takashi Murakami, Andy Hee-Meng Tan, Kong-Peng Lam
An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses. Cells 12 (2) (2023)
Jimmy Bok Yan So, Ritika Kapoor, Feng Zhu, Calvin Jianyi Koh, Lihan Zhou, Ruiyang Zou, Yew Chung Tang, Patrick C K Goo, Sun Young Rha, Hyun Cheol Chung, Joanne Yoong, Celestial T Yap, Jaideepraj Rao, Chung-King Chia, Stephen Tsao, Asim Shabbir, Jonathan Wei Jie Lee, Andy Hee-Meng Tan, Mikael Hartman, Wei Peng Yong, Heng-Phon Too, Khay-Guan Yeoh
Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 70 (5) (2020)

Andy Hee-Meng Tan.css-eqlu8i{font-size:small;padding-left:4px;} (Kong-Peng Lam)